Boom Times For Autoimmune Disease Therapies

Boom Times For Autoimmune Disease Therapies
In this week’s edition of InnovationRx, we look at the boom in autoimmune disease therapies, OpenAI’s healthcare push, Vertex’s $10 billion purchase of Crinetics, and more.